nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—Ospemifene—Tamoxifen—pancreatic cancer	0.488	1	CrCrCtD
Pentamidine—CYP1A1—Dacarbazine—pancreatic cancer	0.0425	0.116	CbGbCtD
Pentamidine—CYP1A1—Tamoxifen—pancreatic cancer	0.0338	0.0921	CbGbCtD
Pentamidine—CYP1A1—Erlotinib—pancreatic cancer	0.0288	0.0783	CbGbCtD
Pentamidine—CYP3A5—Tamoxifen—pancreatic cancer	0.0203	0.0553	CbGbCtD
Pentamidine—CYP2C8—Tamoxifen—pancreatic cancer	0.0195	0.0532	CbGbCtD
Pentamidine—CYP1A2—Dacarbazine—pancreatic cancer	0.019	0.0517	CbGbCtD
Pentamidine—CYP3A5—Erlotinib—pancreatic cancer	0.0173	0.047	CbGbCtD
Pentamidine—CYP2C8—Erlotinib—pancreatic cancer	0.0166	0.0452	CbGbCtD
Pentamidine—CYP2C19—Tamoxifen—pancreatic cancer	0.0164	0.0446	CbGbCtD
Pentamidine—CYP3A5—Irinotecan—pancreatic cancer	0.0156	0.0425	CbGbCtD
Pentamidine—CYP1A2—Tamoxifen—pancreatic cancer	0.0151	0.0411	CbGbCtD
Pentamidine—CYP2C8—Fluorouracil—pancreatic cancer	0.0144	0.0392	CbGbCtD
Pentamidine—CYP1A2—Erlotinib—pancreatic cancer	0.0129	0.035	CbGbCtD
Pentamidine—CYP2D6—Tamoxifen—pancreatic cancer	0.0125	0.0339	CbGbCtD
Pentamidine—CYP3A5—Docetaxel—pancreatic cancer	0.0114	0.0311	CbGbCtD
Pentamidine—CYP3A5—Sunitinib—pancreatic cancer	0.0114	0.031	CbGbCtD
Pentamidine—CYP1A2—Fluorouracil—pancreatic cancer	0.0111	0.0303	CbGbCtD
Pentamidine—CYP2D6—Erlotinib—pancreatic cancer	0.0106	0.0288	CbGbCtD
Pentamidine—CYP3A4—Tamoxifen—pancreatic cancer	0.00792	0.0216	CbGbCtD
Pentamidine—CYP3A4—Erlotinib—pancreatic cancer	0.00674	0.0183	CbGbCtD
Pentamidine—CYP3A4—Irinotecan—pancreatic cancer	0.00608	0.0166	CbGbCtD
Pentamidine—CYP2D6—Doxorubicin—pancreatic cancer	0.00523	0.0142	CbGbCtD
Pentamidine—CYP3A4—Docetaxel—pancreatic cancer	0.00446	0.0121	CbGbCtD
Pentamidine—CYP3A4—Sunitinib—pancreatic cancer	0.00444	0.0121	CbGbCtD
Pentamidine—CYP3A4—Doxorubicin—pancreatic cancer	0.00332	0.00904	CbGbCtD
Pentamidine—Diarrhoea—Sunitinib—pancreatic cancer	9.5e-05	0.000704	CcSEcCtD
Pentamidine—Dysgeusia—Docetaxel—pancreatic cancer	9.49e-05	0.000703	CcSEcCtD
Pentamidine—Feeling abnormal—Irinotecan—pancreatic cancer	9.43e-05	0.000699	CcSEcCtD
Pentamidine—Blood creatinine increased—Doxorubicin—pancreatic cancer	9.41e-05	0.000697	CcSEcCtD
Pentamidine—Influenza—Epirubicin—pancreatic cancer	9.38e-05	0.000695	CcSEcCtD
Pentamidine—Asthma—Epirubicin—pancreatic cancer	9.38e-05	0.000695	CcSEcCtD
Pentamidine—Pain—Fluorouracil—pancreatic cancer	9.37e-05	0.000694	CcSEcCtD
Pentamidine—Gastrointestinal pain—Irinotecan—pancreatic cancer	9.35e-05	0.000693	CcSEcCtD
Pentamidine—Eosinophilia—Epirubicin—pancreatic cancer	9.29e-05	0.000688	CcSEcCtD
Pentamidine—Liver function test abnormal—Doxorubicin—pancreatic cancer	9.27e-05	0.000687	CcSEcCtD
Pentamidine—Dry skin—Doxorubicin—pancreatic cancer	9.2e-05	0.000682	CcSEcCtD
Pentamidine—Pancreatitis—Epirubicin—pancreatic cancer	9.2e-05	0.000682	CcSEcCtD
Pentamidine—Dizziness—Sunitinib—pancreatic cancer	9.18e-05	0.000681	CcSEcCtD
Pentamidine—Feeling abnormal—Gemcitabine—pancreatic cancer	9.18e-05	0.000681	CcSEcCtD
Pentamidine—Abdominal pain—Irinotecan—pancreatic cancer	9.04e-05	0.00067	CcSEcCtD
Pentamidine—Body temperature increased—Irinotecan—pancreatic cancer	9.04e-05	0.00067	CcSEcCtD
Pentamidine—Feeling abnormal—Fluorouracil—pancreatic cancer	9.03e-05	0.000669	CcSEcCtD
Pentamidine—Bronchitis—Epirubicin—pancreatic cancer	9.02e-05	0.000669	CcSEcCtD
Pentamidine—Anaemia—Docetaxel—pancreatic cancer	8.96e-05	0.000664	CcSEcCtD
Pentamidine—Pancytopenia—Epirubicin—pancreatic cancer	8.91e-05	0.00066	CcSEcCtD
Pentamidine—Gastritis—Doxorubicin—pancreatic cancer	8.89e-05	0.000659	CcSEcCtD
Pentamidine—Vomiting—Sunitinib—pancreatic cancer	8.83e-05	0.000654	CcSEcCtD
Pentamidine—Body temperature increased—Gemcitabine—pancreatic cancer	8.81e-05	0.000653	CcSEcCtD
Pentamidine—Neutropenia—Epirubicin—pancreatic cancer	8.77e-05	0.00065	CcSEcCtD
Pentamidine—Rash—Sunitinib—pancreatic cancer	8.76e-05	0.000649	CcSEcCtD
Pentamidine—Dermatitis—Sunitinib—pancreatic cancer	8.75e-05	0.000648	CcSEcCtD
Pentamidine—Urticaria—Fluorouracil—pancreatic cancer	8.7e-05	0.000645	CcSEcCtD
Pentamidine—Headache—Sunitinib—pancreatic cancer	8.7e-05	0.000645	CcSEcCtD
Pentamidine—Syncope—Docetaxel—pancreatic cancer	8.69e-05	0.000644	CcSEcCtD
Pentamidine—Asthma—Doxorubicin—pancreatic cancer	8.68e-05	0.000643	CcSEcCtD
Pentamidine—Influenza—Doxorubicin—pancreatic cancer	8.68e-05	0.000643	CcSEcCtD
Pentamidine—Leukopenia—Docetaxel—pancreatic cancer	8.67e-05	0.000643	CcSEcCtD
Pentamidine—Body temperature increased—Fluorouracil—pancreatic cancer	8.66e-05	0.000642	CcSEcCtD
Pentamidine—Eosinophilia—Doxorubicin—pancreatic cancer	8.59e-05	0.000637	CcSEcCtD
Pentamidine—Palpitations—Docetaxel—pancreatic cancer	8.56e-05	0.000635	CcSEcCtD
Pentamidine—Loss of consciousness—Docetaxel—pancreatic cancer	8.52e-05	0.000631	CcSEcCtD
Pentamidine—Pancreatitis—Doxorubicin—pancreatic cancer	8.51e-05	0.000631	CcSEcCtD
Pentamidine—Hyperglycaemia—Epirubicin—pancreatic cancer	8.46e-05	0.000627	CcSEcCtD
Pentamidine—Cough—Docetaxel—pancreatic cancer	8.46e-05	0.000627	CcSEcCtD
Pentamidine—Hypersensitivity—Irinotecan—pancreatic cancer	8.43e-05	0.000625	CcSEcCtD
Pentamidine—Convulsion—Docetaxel—pancreatic cancer	8.4e-05	0.000622	CcSEcCtD
Pentamidine—Hypertension—Docetaxel—pancreatic cancer	8.37e-05	0.00062	CcSEcCtD
Pentamidine—Drowsiness—Epirubicin—pancreatic cancer	8.36e-05	0.00062	CcSEcCtD
Pentamidine—Bronchitis—Doxorubicin—pancreatic cancer	8.35e-05	0.000619	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	8.29e-05	0.000614	CcSEcCtD
Pentamidine—Chest pain—Docetaxel—pancreatic cancer	8.25e-05	0.000611	CcSEcCtD
Pentamidine—Arthralgia—Docetaxel—pancreatic cancer	8.25e-05	0.000611	CcSEcCtD
Pentamidine—Myalgia—Docetaxel—pancreatic cancer	8.25e-05	0.000611	CcSEcCtD
Pentamidine—Nausea—Sunitinib—pancreatic cancer	8.25e-05	0.000611	CcSEcCtD
Pentamidine—Pancytopenia—Doxorubicin—pancreatic cancer	8.24e-05	0.000611	CcSEcCtD
Pentamidine—Renal failure—Epirubicin—pancreatic cancer	8.22e-05	0.000609	CcSEcCtD
Pentamidine—Asthenia—Irinotecan—pancreatic cancer	8.21e-05	0.000608	CcSEcCtD
Pentamidine—Neuropathy peripheral—Epirubicin—pancreatic cancer	8.2e-05	0.000608	CcSEcCtD
Pentamidine—Stomatitis—Epirubicin—pancreatic cancer	8.15e-05	0.000604	CcSEcCtD
Pentamidine—Conjunctivitis—Epirubicin—pancreatic cancer	8.13e-05	0.000602	CcSEcCtD
Pentamidine—Neutropenia—Doxorubicin—pancreatic cancer	8.12e-05	0.000601	CcSEcCtD
Pentamidine—Hypersensitivity—Fluorouracil—pancreatic cancer	8.07e-05	0.000598	CcSEcCtD
Pentamidine—Dry mouth—Docetaxel—pancreatic cancer	8.07e-05	0.000598	CcSEcCtD
Pentamidine—Asthenia—Gemcitabine—pancreatic cancer	8e-05	0.000593	CcSEcCtD
Pentamidine—Haematuria—Epirubicin—pancreatic cancer	7.97e-05	0.000591	CcSEcCtD
Pentamidine—Confusional state—Docetaxel—pancreatic cancer	7.97e-05	0.000591	CcSEcCtD
Pentamidine—Anaphylactic shock—Docetaxel—pancreatic cancer	7.91e-05	0.000586	CcSEcCtD
Pentamidine—Pruritus—Gemcitabine—pancreatic cancer	7.88e-05	0.000584	CcSEcCtD
Pentamidine—Infection—Docetaxel—pancreatic cancer	7.86e-05	0.000582	CcSEcCtD
Pentamidine—Sinusitis—Epirubicin—pancreatic cancer	7.85e-05	0.000581	CcSEcCtD
Pentamidine—Hyperglycaemia—Doxorubicin—pancreatic cancer	7.83e-05	0.00058	CcSEcCtD
Pentamidine—Diarrhoea—Irinotecan—pancreatic cancer	7.83e-05	0.00058	CcSEcCtD
Pentamidine—Shock—Docetaxel—pancreatic cancer	7.78e-05	0.000577	CcSEcCtD
Pentamidine—Pruritus—Fluorouracil—pancreatic cancer	7.75e-05	0.000574	CcSEcCtD
Pentamidine—Thrombocytopenia—Docetaxel—pancreatic cancer	7.74e-05	0.000574	CcSEcCtD
Pentamidine—Drowsiness—Doxorubicin—pancreatic cancer	7.74e-05	0.000573	CcSEcCtD
Pentamidine—Tachycardia—Docetaxel—pancreatic cancer	7.72e-05	0.000572	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	7.67e-05	0.000569	CcSEcCtD
Pentamidine—Bradycardia—Epirubicin—pancreatic cancer	7.64e-05	0.000566	CcSEcCtD
Pentamidine—Diarrhoea—Gemcitabine—pancreatic cancer	7.62e-05	0.000565	CcSEcCtD
Pentamidine—Renal failure—Doxorubicin—pancreatic cancer	7.61e-05	0.000564	CcSEcCtD
Pentamidine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	7.59e-05	0.000562	CcSEcCtD
Pentamidine—Dizziness—Irinotecan—pancreatic cancer	7.56e-05	0.000561	CcSEcCtD
Pentamidine—Stomatitis—Doxorubicin—pancreatic cancer	7.54e-05	0.000559	CcSEcCtD
Pentamidine—Anorexia—Docetaxel—pancreatic cancer	7.54e-05	0.000559	CcSEcCtD
Pentamidine—Rhinitis—Epirubicin—pancreatic cancer	7.53e-05	0.000558	CcSEcCtD
Pentamidine—Conjunctivitis—Doxorubicin—pancreatic cancer	7.52e-05	0.000557	CcSEcCtD
Pentamidine—Hepatitis—Epirubicin—pancreatic cancer	7.51e-05	0.000556	CcSEcCtD
Pentamidine—Diarrhoea—Fluorouracil—pancreatic cancer	7.5e-05	0.000556	CcSEcCtD
Pentamidine—Hypoaesthesia—Epirubicin—pancreatic cancer	7.47e-05	0.000554	CcSEcCtD
Pentamidine—Pharyngitis—Epirubicin—pancreatic cancer	7.45e-05	0.000552	CcSEcCtD
Pentamidine—Oedema peripheral—Epirubicin—pancreatic cancer	7.4e-05	0.000548	CcSEcCtD
Pentamidine—Hypotension—Docetaxel—pancreatic cancer	7.39e-05	0.000548	CcSEcCtD
Pentamidine—Haematuria—Doxorubicin—pancreatic cancer	7.38e-05	0.000547	CcSEcCtD
Pentamidine—Vomiting—Irinotecan—pancreatic cancer	7.27e-05	0.000539	CcSEcCtD
Pentamidine—Sinusitis—Doxorubicin—pancreatic cancer	7.26e-05	0.000538	CcSEcCtD
Pentamidine—Dizziness—Fluorouracil—pancreatic cancer	7.25e-05	0.000537	CcSEcCtD
Pentamidine—Rash—Irinotecan—pancreatic cancer	7.21e-05	0.000535	CcSEcCtD
Pentamidine—Dermatitis—Irinotecan—pancreatic cancer	7.21e-05	0.000534	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.2e-05	0.000534	CcSEcCtD
Pentamidine—Headache—Irinotecan—pancreatic cancer	7.17e-05	0.000531	CcSEcCtD
Pentamidine—Insomnia—Docetaxel—pancreatic cancer	7.15e-05	0.00053	CcSEcCtD
Pentamidine—Paraesthesia—Docetaxel—pancreatic cancer	7.1e-05	0.000526	CcSEcCtD
Pentamidine—Erythema multiforme—Epirubicin—pancreatic cancer	7.1e-05	0.000526	CcSEcCtD
Pentamidine—Vomiting—Gemcitabine—pancreatic cancer	7.09e-05	0.000525	CcSEcCtD
Pentamidine—Bradycardia—Doxorubicin—pancreatic cancer	7.07e-05	0.000524	CcSEcCtD
Pentamidine—Dyspnoea—Docetaxel—pancreatic cancer	7.05e-05	0.000522	CcSEcCtD
Pentamidine—Somnolence—Docetaxel—pancreatic cancer	7.03e-05	0.000521	CcSEcCtD
Pentamidine—Rash—Gemcitabine—pancreatic cancer	7.03e-05	0.000521	CcSEcCtD
Pentamidine—Dermatitis—Gemcitabine—pancreatic cancer	7.02e-05	0.00052	CcSEcCtD
Pentamidine—Headache—Gemcitabine—pancreatic cancer	6.98e-05	0.000517	CcSEcCtD
Pentamidine—Flushing—Epirubicin—pancreatic cancer	6.97e-05	0.000516	CcSEcCtD
Pentamidine—Vomiting—Fluorouracil—pancreatic cancer	6.97e-05	0.000516	CcSEcCtD
Pentamidine—Rhinitis—Doxorubicin—pancreatic cancer	6.96e-05	0.000516	CcSEcCtD
Pentamidine—Dyspepsia—Docetaxel—pancreatic cancer	6.96e-05	0.000516	CcSEcCtD
Pentamidine—Hepatitis—Doxorubicin—pancreatic cancer	6.95e-05	0.000515	CcSEcCtD
Pentamidine—Hypoaesthesia—Doxorubicin—pancreatic cancer	6.91e-05	0.000512	CcSEcCtD
Pentamidine—Rash—Fluorouracil—pancreatic cancer	6.91e-05	0.000512	CcSEcCtD
Pentamidine—Dermatitis—Fluorouracil—pancreatic cancer	6.9e-05	0.000511	CcSEcCtD
Pentamidine—Pharyngitis—Doxorubicin—pancreatic cancer	6.89e-05	0.000511	CcSEcCtD
Pentamidine—Decreased appetite—Docetaxel—pancreatic cancer	6.87e-05	0.000509	CcSEcCtD
Pentamidine—Headache—Fluorouracil—pancreatic cancer	6.86e-05	0.000509	CcSEcCtD
Pentamidine—Oedema peripheral—Doxorubicin—pancreatic cancer	6.84e-05	0.000507	CcSEcCtD
Pentamidine—Fatigue—Docetaxel—pancreatic cancer	6.82e-05	0.000505	CcSEcCtD
Pentamidine—Nausea—Irinotecan—pancreatic cancer	6.79e-05	0.000504	CcSEcCtD
Pentamidine—Pain—Docetaxel—pancreatic cancer	6.76e-05	0.000501	CcSEcCtD
Pentamidine—Constipation—Docetaxel—pancreatic cancer	6.76e-05	0.000501	CcSEcCtD
Pentamidine—Chills—Epirubicin—pancreatic cancer	6.74e-05	0.000499	CcSEcCtD
Pentamidine—Arrhythmia—Epirubicin—pancreatic cancer	6.71e-05	0.000497	CcSEcCtD
Pentamidine—Nausea—Gemcitabine—pancreatic cancer	6.62e-05	0.000491	CcSEcCtD
Pentamidine—Erythema multiforme—Doxorubicin—pancreatic cancer	6.57e-05	0.000487	CcSEcCtD
Pentamidine—Erythema—Epirubicin—pancreatic cancer	6.54e-05	0.000484	CcSEcCtD
Pentamidine—Feeling abnormal—Docetaxel—pancreatic cancer	6.52e-05	0.000483	CcSEcCtD
Pentamidine—Nausea—Fluorouracil—pancreatic cancer	6.51e-05	0.000482	CcSEcCtD
Pentamidine—Gastrointestinal pain—Docetaxel—pancreatic cancer	6.47e-05	0.000479	CcSEcCtD
Pentamidine—Flushing—Doxorubicin—pancreatic cancer	6.45e-05	0.000478	CcSEcCtD
Pentamidine—Tension—Epirubicin—pancreatic cancer	6.41e-05	0.000475	CcSEcCtD
Pentamidine—Dysgeusia—Epirubicin—pancreatic cancer	6.4e-05	0.000474	CcSEcCtD
Pentamidine—Nervousness—Epirubicin—pancreatic cancer	6.35e-05	0.00047	CcSEcCtD
Pentamidine—Body temperature increased—Docetaxel—pancreatic cancer	6.25e-05	0.000463	CcSEcCtD
Pentamidine—Abdominal pain—Docetaxel—pancreatic cancer	6.25e-05	0.000463	CcSEcCtD
Pentamidine—Chills—Doxorubicin—pancreatic cancer	6.23e-05	0.000462	CcSEcCtD
Pentamidine—Arrhythmia—Doxorubicin—pancreatic cancer	6.21e-05	0.00046	CcSEcCtD
Pentamidine—Vision blurred—Epirubicin—pancreatic cancer	6.16e-05	0.000456	CcSEcCtD
Pentamidine—Erythema—Doxorubicin—pancreatic cancer	6.05e-05	0.000448	CcSEcCtD
Pentamidine—Anaemia—Epirubicin—pancreatic cancer	6.04e-05	0.000448	CcSEcCtD
Pentamidine—Tension—Doxorubicin—pancreatic cancer	5.93e-05	0.00044	CcSEcCtD
Pentamidine—Dysgeusia—Doxorubicin—pancreatic cancer	5.92e-05	0.000439	CcSEcCtD
Pentamidine—Nervousness—Doxorubicin—pancreatic cancer	5.87e-05	0.000435	CcSEcCtD
Pentamidine—Vertigo—Epirubicin—pancreatic cancer	5.87e-05	0.000435	CcSEcCtD
Pentamidine—Syncope—Epirubicin—pancreatic cancer	5.86e-05	0.000434	CcSEcCtD
Pentamidine—Leukopenia—Epirubicin—pancreatic cancer	5.85e-05	0.000434	CcSEcCtD
Pentamidine—Hypersensitivity—Docetaxel—pancreatic cancer	5.83e-05	0.000432	CcSEcCtD
Pentamidine—Palpitations—Epirubicin—pancreatic cancer	5.78e-05	0.000428	CcSEcCtD
Pentamidine—Loss of consciousness—Epirubicin—pancreatic cancer	5.74e-05	0.000426	CcSEcCtD
Pentamidine—Cough—Epirubicin—pancreatic cancer	5.7e-05	0.000423	CcSEcCtD
Pentamidine—Vision blurred—Doxorubicin—pancreatic cancer	5.7e-05	0.000422	CcSEcCtD
Pentamidine—Asthenia—Docetaxel—pancreatic cancer	5.67e-05	0.00042	CcSEcCtD
Pentamidine—Convulsion—Epirubicin—pancreatic cancer	5.66e-05	0.00042	CcSEcCtD
Pentamidine—Hypertension—Epirubicin—pancreatic cancer	5.64e-05	0.000418	CcSEcCtD
Pentamidine—Pruritus—Docetaxel—pancreatic cancer	5.59e-05	0.000415	CcSEcCtD
Pentamidine—Anaemia—Doxorubicin—pancreatic cancer	5.59e-05	0.000414	CcSEcCtD
Pentamidine—Chest pain—Epirubicin—pancreatic cancer	5.56e-05	0.000412	CcSEcCtD
Pentamidine—Arthralgia—Epirubicin—pancreatic cancer	5.56e-05	0.000412	CcSEcCtD
Pentamidine—Myalgia—Epirubicin—pancreatic cancer	5.56e-05	0.000412	CcSEcCtD
Pentamidine—Anxiety—Epirubicin—pancreatic cancer	5.54e-05	0.000411	CcSEcCtD
Pentamidine—Discomfort—Epirubicin—pancreatic cancer	5.5e-05	0.000407	CcSEcCtD
Pentamidine—Dry mouth—Epirubicin—pancreatic cancer	5.44e-05	0.000403	CcSEcCtD
Pentamidine—Vertigo—Doxorubicin—pancreatic cancer	5.43e-05	0.000403	CcSEcCtD
Pentamidine—Syncope—Doxorubicin—pancreatic cancer	5.42e-05	0.000402	CcSEcCtD
Pentamidine—Leukopenia—Doxorubicin—pancreatic cancer	5.41e-05	0.000401	CcSEcCtD
Pentamidine—Diarrhoea—Docetaxel—pancreatic cancer	5.41e-05	0.000401	CcSEcCtD
Pentamidine—Confusional state—Epirubicin—pancreatic cancer	5.38e-05	0.000399	CcSEcCtD
Pentamidine—Palpitations—Doxorubicin—pancreatic cancer	5.34e-05	0.000396	CcSEcCtD
Pentamidine—Anaphylactic shock—Epirubicin—pancreatic cancer	5.33e-05	0.000395	CcSEcCtD
Pentamidine—Loss of consciousness—Doxorubicin—pancreatic cancer	5.31e-05	0.000394	CcSEcCtD
Pentamidine—Infection—Epirubicin—pancreatic cancer	5.3e-05	0.000393	CcSEcCtD
Pentamidine—Cough—Doxorubicin—pancreatic cancer	5.28e-05	0.000391	CcSEcCtD
Pentamidine—Shock—Epirubicin—pancreatic cancer	5.25e-05	0.000389	CcSEcCtD
Pentamidine—Convulsion—Doxorubicin—pancreatic cancer	5.24e-05	0.000388	CcSEcCtD
Pentamidine—Dizziness—Docetaxel—pancreatic cancer	5.23e-05	0.000388	CcSEcCtD
Pentamidine—Thrombocytopenia—Epirubicin—pancreatic cancer	5.22e-05	0.000387	CcSEcCtD
Pentamidine—Hypertension—Doxorubicin—pancreatic cancer	5.22e-05	0.000387	CcSEcCtD
Pentamidine—Tachycardia—Epirubicin—pancreatic cancer	5.21e-05	0.000386	CcSEcCtD
Pentamidine—Chest pain—Doxorubicin—pancreatic cancer	5.15e-05	0.000382	CcSEcCtD
Pentamidine—Arthralgia—Doxorubicin—pancreatic cancer	5.15e-05	0.000382	CcSEcCtD
Pentamidine—Myalgia—Doxorubicin—pancreatic cancer	5.15e-05	0.000382	CcSEcCtD
Pentamidine—Anxiety—Doxorubicin—pancreatic cancer	5.13e-05	0.00038	CcSEcCtD
Pentamidine—Discomfort—Doxorubicin—pancreatic cancer	5.09e-05	0.000377	CcSEcCtD
Pentamidine—Anorexia—Epirubicin—pancreatic cancer	5.08e-05	0.000377	CcSEcCtD
Pentamidine—Dry mouth—Doxorubicin—pancreatic cancer	5.03e-05	0.000373	CcSEcCtD
Pentamidine—Vomiting—Docetaxel—pancreatic cancer	5.03e-05	0.000373	CcSEcCtD
Pentamidine—Rash—Docetaxel—pancreatic cancer	4.99e-05	0.00037	CcSEcCtD
Pentamidine—Hypotension—Epirubicin—pancreatic cancer	4.98e-05	0.000369	CcSEcCtD
Pentamidine—Dermatitis—Docetaxel—pancreatic cancer	4.98e-05	0.000369	CcSEcCtD
Pentamidine—Confusional state—Doxorubicin—pancreatic cancer	4.98e-05	0.000369	CcSEcCtD
Pentamidine—Headache—Docetaxel—pancreatic cancer	4.95e-05	0.000367	CcSEcCtD
Pentamidine—Anaphylactic shock—Doxorubicin—pancreatic cancer	4.94e-05	0.000366	CcSEcCtD
Pentamidine—Infection—Doxorubicin—pancreatic cancer	4.9e-05	0.000363	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	4.86e-05	0.00036	CcSEcCtD
Pentamidine—Shock—Doxorubicin—pancreatic cancer	4.86e-05	0.00036	CcSEcCtD
Pentamidine—Thrombocytopenia—Doxorubicin—pancreatic cancer	4.83e-05	0.000358	CcSEcCtD
Pentamidine—Insomnia—Epirubicin—pancreatic cancer	4.82e-05	0.000358	CcSEcCtD
Pentamidine—Tachycardia—Doxorubicin—pancreatic cancer	4.82e-05	0.000357	CcSEcCtD
Pentamidine—Paraesthesia—Epirubicin—pancreatic cancer	4.79e-05	0.000355	CcSEcCtD
Pentamidine—Dyspnoea—Epirubicin—pancreatic cancer	4.76e-05	0.000352	CcSEcCtD
Pentamidine—Somnolence—Epirubicin—pancreatic cancer	4.74e-05	0.000351	CcSEcCtD
Pentamidine—Anorexia—Doxorubicin—pancreatic cancer	4.7e-05	0.000349	CcSEcCtD
Pentamidine—Nausea—Docetaxel—pancreatic cancer	4.7e-05	0.000348	CcSEcCtD
Pentamidine—Dyspepsia—Epirubicin—pancreatic cancer	4.7e-05	0.000348	CcSEcCtD
Pentamidine—Decreased appetite—Epirubicin—pancreatic cancer	4.64e-05	0.000344	CcSEcCtD
Pentamidine—Hypotension—Doxorubicin—pancreatic cancer	4.61e-05	0.000342	CcSEcCtD
Pentamidine—Fatigue—Epirubicin—pancreatic cancer	4.6e-05	0.000341	CcSEcCtD
Pentamidine—Pain—Epirubicin—pancreatic cancer	4.56e-05	0.000338	CcSEcCtD
Pentamidine—Constipation—Epirubicin—pancreatic cancer	4.56e-05	0.000338	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.5e-05	0.000333	CcSEcCtD
Pentamidine—Insomnia—Doxorubicin—pancreatic cancer	4.46e-05	0.000331	CcSEcCtD
Pentamidine—Paraesthesia—Doxorubicin—pancreatic cancer	4.43e-05	0.000328	CcSEcCtD
Pentamidine—Dyspnoea—Doxorubicin—pancreatic cancer	4.4e-05	0.000326	CcSEcCtD
Pentamidine—Feeling abnormal—Epirubicin—pancreatic cancer	4.4e-05	0.000326	CcSEcCtD
Pentamidine—Somnolence—Doxorubicin—pancreatic cancer	4.39e-05	0.000325	CcSEcCtD
Pentamidine—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.36e-05	0.000323	CcSEcCtD
Pentamidine—Dyspepsia—Doxorubicin—pancreatic cancer	4.34e-05	0.000322	CcSEcCtD
Pentamidine—Decreased appetite—Doxorubicin—pancreatic cancer	4.29e-05	0.000318	CcSEcCtD
Pentamidine—Fatigue—Doxorubicin—pancreatic cancer	4.25e-05	0.000315	CcSEcCtD
Pentamidine—Urticaria—Epirubicin—pancreatic cancer	4.24e-05	0.000314	CcSEcCtD
Pentamidine—Pain—Doxorubicin—pancreatic cancer	4.22e-05	0.000313	CcSEcCtD
Pentamidine—Constipation—Doxorubicin—pancreatic cancer	4.22e-05	0.000313	CcSEcCtD
Pentamidine—Abdominal pain—Epirubicin—pancreatic cancer	4.22e-05	0.000312	CcSEcCtD
Pentamidine—Body temperature increased—Epirubicin—pancreatic cancer	4.22e-05	0.000312	CcSEcCtD
Pentamidine—Feeling abnormal—Doxorubicin—pancreatic cancer	4.07e-05	0.000301	CcSEcCtD
Pentamidine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.04e-05	0.000299	CcSEcCtD
Pentamidine—Hypersensitivity—Epirubicin—pancreatic cancer	3.93e-05	0.000291	CcSEcCtD
Pentamidine—Urticaria—Doxorubicin—pancreatic cancer	3.92e-05	0.000291	CcSEcCtD
Pentamidine—Abdominal pain—Doxorubicin—pancreatic cancer	3.9e-05	0.000289	CcSEcCtD
Pentamidine—Body temperature increased—Doxorubicin—pancreatic cancer	3.9e-05	0.000289	CcSEcCtD
Pentamidine—Asthenia—Epirubicin—pancreatic cancer	3.83e-05	0.000284	CcSEcCtD
Pentamidine—Pruritus—Epirubicin—pancreatic cancer	3.77e-05	0.00028	CcSEcCtD
Pentamidine—Diarrhoea—Epirubicin—pancreatic cancer	3.65e-05	0.00027	CcSEcCtD
Pentamidine—Hypersensitivity—Doxorubicin—pancreatic cancer	3.64e-05	0.000269	CcSEcCtD
Pentamidine—Asthenia—Doxorubicin—pancreatic cancer	3.54e-05	0.000262	CcSEcCtD
Pentamidine—Dizziness—Epirubicin—pancreatic cancer	3.53e-05	0.000261	CcSEcCtD
Pentamidine—Pruritus—Doxorubicin—pancreatic cancer	3.49e-05	0.000259	CcSEcCtD
Pentamidine—Vomiting—Epirubicin—pancreatic cancer	3.39e-05	0.000251	CcSEcCtD
Pentamidine—Diarrhoea—Doxorubicin—pancreatic cancer	3.38e-05	0.00025	CcSEcCtD
Pentamidine—Rash—Epirubicin—pancreatic cancer	3.36e-05	0.000249	CcSEcCtD
Pentamidine—Dermatitis—Epirubicin—pancreatic cancer	3.36e-05	0.000249	CcSEcCtD
Pentamidine—Headache—Epirubicin—pancreatic cancer	3.34e-05	0.000248	CcSEcCtD
Pentamidine—Dizziness—Doxorubicin—pancreatic cancer	3.26e-05	0.000242	CcSEcCtD
Pentamidine—Nausea—Epirubicin—pancreatic cancer	3.17e-05	0.000235	CcSEcCtD
Pentamidine—Vomiting—Doxorubicin—pancreatic cancer	3.14e-05	0.000233	CcSEcCtD
Pentamidine—Rash—Doxorubicin—pancreatic cancer	3.11e-05	0.000231	CcSEcCtD
Pentamidine—Dermatitis—Doxorubicin—pancreatic cancer	3.11e-05	0.00023	CcSEcCtD
Pentamidine—Headache—Doxorubicin—pancreatic cancer	3.09e-05	0.000229	CcSEcCtD
Pentamidine—Nausea—Doxorubicin—pancreatic cancer	2.93e-05	0.000217	CcSEcCtD
Pentamidine—S100B—Signaling Pathways—AGTR1—pancreatic cancer	1.21e-05	0.00128	CbGpPWpGaD
Pentamidine—S100B—Immune System—NFKBIA—pancreatic cancer	1.2e-05	0.00127	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—DPYD—pancreatic cancer	1.2e-05	0.00127	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—STK11—pancreatic cancer	1.19e-05	0.00126	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—NRAS—pancreatic cancer	1.18e-05	0.00125	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	1.17e-05	0.00124	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	1.17e-05	0.00124	CbGpPWpGaD
Pentamidine—S100B—Immune System—EGF—pancreatic cancer	1.15e-05	0.00122	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	1.14e-05	0.00121	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	1.14e-05	0.00121	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—SLC2A2—pancreatic cancer	1.14e-05	0.0012	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.12e-05	0.00119	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	1.09e-05	0.00116	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	1.09e-05	0.00116	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.08e-05	0.00115	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	1.08e-05	0.00115	CbGpPWpGaD
Pentamidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	1.08e-05	0.00115	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—EGFR—pancreatic cancer	1.08e-05	0.00114	CbGpPWpGaD
Pentamidine—S100B—Immune System—CDH1—pancreatic cancer	1.07e-05	0.00114	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SMAD4—pancreatic cancer	1.05e-05	0.00111	CbGpPWpGaD
Pentamidine—S100B—Immune System—PIK3CD—pancreatic cancer	1.02e-05	0.00109	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HES1—pancreatic cancer	1.02e-05	0.00108	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—KRAS—pancreatic cancer	1.02e-05	0.00108	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.88e-06	0.00105	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—PIK3CA—pancreatic cancer	9.34e-06	0.00099	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	9.19e-06	0.000974	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TERT—pancreatic cancer	8.94e-06	0.000947	CbGpPWpGaD
Pentamidine—S100B—Immune System—PIK3CB—pancreatic cancer	8.93e-06	0.000946	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CD44—pancreatic cancer	8.79e-06	0.000932	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—HRAS—pancreatic cancer	8.65e-06	0.000916	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.61e-06	0.000912	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HIF1A—pancreatic cancer	8.55e-06	0.000906	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.53e-06	0.000904	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TSC2—pancreatic cancer	8.53e-06	0.000904	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—GCG—pancreatic cancer	8.43e-06	0.000893	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PRSS1—pancreatic cancer	8.36e-06	0.000886	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—APOE—pancreatic cancer	8.35e-06	0.000884	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—KDR—pancreatic cancer	8.18e-06	0.000866	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—STK11—pancreatic cancer	7.93e-06	0.00084	CbGpPWpGaD
Pentamidine—S100B—Immune System—CTNNB1—pancreatic cancer	7.92e-06	0.000839	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PRSS1—pancreatic cancer	7.9e-06	0.000837	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—NFKBIA—pancreatic cancer	7.78e-06	0.000824	CbGpPWpGaD
Pentamidine—S100B—Immune System—PTEN—pancreatic cancer	7.72e-06	0.000817	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—NOTCH1—pancreatic cancer	7.7e-06	0.000816	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—AKT1—pancreatic cancer	7.63e-06	0.000809	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CG—pancreatic cancer	7.53e-06	0.000798	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EGF—pancreatic cancer	7.45e-06	0.000789	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.44e-06	0.000788	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ARG2—pancreatic cancer	7.25e-06	0.000768	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PRSS1—pancreatic cancer	7.24e-06	0.000768	CbGpPWpGaD
Pentamidine—S100B—Immune System—SRC—pancreatic cancer	7.15e-06	0.000758	CbGpPWpGaD
Pentamidine—S100B—Immune System—STAT3—pancreatic cancer	6.9e-06	0.000731	CbGpPWpGaD
Pentamidine—S100B—Immune System—NRAS—pancreatic cancer	6.88e-06	0.000729	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ARG2—pancreatic cancer	6.85e-06	0.000726	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—TYMS—pancreatic cancer	6.82e-06	0.000722	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CD—pancreatic cancer	6.62e-06	0.000702	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PRSS1—pancreatic cancer	6.47e-06	0.000685	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—TYMP—pancreatic cancer	6.34e-06	0.000672	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ARG2—pancreatic cancer	6.28e-06	0.000666	CbGpPWpGaD
Pentamidine—S100B—Immune System—EGFR—pancreatic cancer	6.27e-06	0.000664	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—TYMP—pancreatic cancer	5.99e-06	0.000635	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	5.95e-06	0.00063	CbGpPWpGaD
Pentamidine—S100B—Immune System—KRAS—pancreatic cancer	5.92e-06	0.000628	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CB—pancreatic cancer	5.77e-06	0.000612	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ARG2—pancreatic cancer	5.61e-06	0.000594	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CXCL8—pancreatic cancer	5.55e-06	0.000588	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—APOE—pancreatic cancer	5.55e-06	0.000588	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—TYMP—pancreatic cancer	5.49e-06	0.000582	CbGpPWpGaD
Pentamidine—S100B—Immune System—PIK3CA—pancreatic cancer	5.44e-06	0.000577	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CASP3—pancreatic cancer	5.31e-06	0.000563	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.25e-06	0.000556	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCND1—pancreatic cancer	5.17e-06	0.000548	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ARG2—pancreatic cancer	5.16e-06	0.000546	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CTNNB1—pancreatic cancer	5.12e-06	0.000542	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GLP1R—pancreatic cancer	5.11e-06	0.000541	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PRSS1—pancreatic cancer	5.04e-06	0.000534	CbGpPWpGaD
Pentamidine—S100B—Immune System—HRAS—pancreatic cancer	5.04e-06	0.000534	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—DPYD—pancreatic cancer	5.03e-06	0.000533	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MMP9—pancreatic cancer	5.02e-06	0.000532	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CG—pancreatic cancer	5e-06	0.00053	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PTEN—pancreatic cancer	4.99e-06	0.000529	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.94e-06	0.000524	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—TYMP—pancreatic cancer	4.9e-06	0.000519	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PPARG—pancreatic cancer	4.83e-06	0.000512	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GLP1R—pancreatic cancer	4.83e-06	0.000511	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	4.77e-06	0.000505	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—DPYD—pancreatic cancer	4.75e-06	0.000503	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SRC—pancreatic cancer	4.63e-06	0.00049	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.53e-06	0.00048	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—TYMP—pancreatic cancer	4.51e-06	0.000478	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—SLC2A2—pancreatic cancer	4.51e-06	0.000477	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VEGFA—pancreatic cancer	4.51e-06	0.000477	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—STAT3—pancreatic cancer	4.46e-06	0.000473	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.46e-06	0.000473	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—NRAS—pancreatic cancer	4.45e-06	0.000472	CbGpPWpGaD
Pentamidine—S100B—Immune System—AKT1—pancreatic cancer	4.45e-06	0.000471	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GLP1R—pancreatic cancer	4.43e-06	0.000469	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CD—pancreatic cancer	4.4e-06	0.000466	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ARG2—pancreatic cancer	4.37e-06	0.000463	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—DPYD—pancreatic cancer	4.35e-06	0.000461	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.3e-06	0.000456	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MYC—pancreatic cancer	4.15e-06	0.000439	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TGFB1—pancreatic cancer	4.14e-06	0.000438	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	4.13e-06	0.000438	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.09e-06	0.000433	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EGFR—pancreatic cancer	4.05e-06	0.00043	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.04e-06	0.000428	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GLP1R—pancreatic cancer	3.95e-06	0.000419	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.95e-06	0.000418	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.92e-06	0.000415	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	3.89e-06	0.000412	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—DPYD—pancreatic cancer	3.89e-06	0.000412	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CB—pancreatic cancer	3.83e-06	0.000406	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—KRAS—pancreatic cancer	3.83e-06	0.000406	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—TYMP—pancreatic cancer	3.82e-06	0.000405	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTGS2—pancreatic cancer	3.8e-06	0.000403	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CD44—pancreatic cancer	3.69e-06	0.000391	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	3.69e-06	0.000391	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.65e-06	0.000387	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	3.63e-06	0.000385	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.59e-06	0.000381	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—DPYD—pancreatic cancer	3.57e-06	0.000379	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GCG—pancreatic cancer	3.54e-06	0.000375	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.52e-06	0.000373	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CA—pancreatic cancer	3.52e-06	0.000373	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CD44—pancreatic cancer	3.49e-06	0.00037	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.42e-06	0.000362	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—pancreatic cancer	3.4e-06	0.000361	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	3.39e-06	0.000359	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.39e-06	0.000359	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ARG2—pancreatic cancer	3.37e-06	0.000357	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GCG—pancreatic cancer	3.35e-06	0.000355	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—STK11—pancreatic cancer	3.33e-06	0.000353	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTEN—pancreatic cancer	3.31e-06	0.000351	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HRAS—pancreatic cancer	3.26e-06	0.000345	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.21e-06	0.00034	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CD44—pancreatic cancer	3.2e-06	0.000339	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.15e-06	0.000334	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—STK11—pancreatic cancer	3.15e-06	0.000333	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.13e-06	0.000332	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.1e-06	0.000329	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GLP1R—pancreatic cancer	3.08e-06	0.000326	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GCG—pancreatic cancer	3.07e-06	0.000325	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—DPYD—pancreatic cancer	3.03e-06	0.000321	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.95e-06	0.000313	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TYMP—pancreatic cancer	2.95e-06	0.000312	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—STK11—pancreatic cancer	2.88e-06	0.000306	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKT1—pancreatic cancer	2.87e-06	0.000305	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	2.87e-06	0.000304	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—TYMS—pancreatic cancer	2.86e-06	0.000303	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CD44—pancreatic cancer	2.86e-06	0.000303	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.84e-06	0.000301	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.8e-06	0.000296	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.77e-06	0.000294	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.74e-06	0.000291	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GCG—pancreatic cancer	2.74e-06	0.00029	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.71e-06	0.000287	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—TYMS—pancreatic cancer	2.71e-06	0.000287	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CD44—pancreatic cancer	2.63e-06	0.000278	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—STK11—pancreatic cancer	2.57e-06	0.000273	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GCG—pancreatic cancer	2.52e-06	0.000267	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.5e-06	0.000265	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—TYMS—pancreatic cancer	2.48e-06	0.000263	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.42e-06	0.000256	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.38e-06	0.000252	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—STK11—pancreatic cancer	2.37e-06	0.000251	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CA—pancreatic cancer	2.34e-06	0.000248	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.34e-06	0.000248	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—APOE—pancreatic cancer	2.33e-06	0.000247	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CD44—pancreatic cancer	2.23e-06	0.000236	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.22e-06	0.000235	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—TYMS—pancreatic cancer	2.21e-06	0.000235	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—APOE—pancreatic cancer	2.2e-06	0.000233	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.18e-06	0.000231	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.16e-06	0.000229	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GCG—pancreatic cancer	2.13e-06	0.000226	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	2.1e-06	0.000223	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.08e-06	0.000221	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—TYMS—pancreatic cancer	2.04e-06	0.000216	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPARG—pancreatic cancer	2.03e-06	0.000215	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—APOE—pancreatic cancer	2.02e-06	0.000214	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—STK11—pancreatic cancer	2.01e-06	0.000213	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	1.99e-06	0.00021	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPARG—pancreatic cancer	1.92e-06	0.000203	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.91e-06	0.000202	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKT1—pancreatic cancer	1.91e-06	0.000202	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.88e-06	0.000199	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	1.85e-06	0.000196	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	1.82e-06	0.000193	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—APOE—pancreatic cancer	1.8e-06	0.000191	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPARG—pancreatic cancer	1.76e-06	0.000186	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	1.75e-06	0.000185	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.73e-06	0.000183	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CD44—pancreatic cancer	1.72e-06	0.000182	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.7e-06	0.000181	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—APOE—pancreatic cancer	1.66e-06	0.000176	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GCG—pancreatic cancer	1.65e-06	0.000174	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	1.63e-06	0.000172	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	1.61e-06	0.000171	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	1.6e-06	0.00017	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS2—pancreatic cancer	1.6e-06	0.000169	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPARG—pancreatic cancer	1.57e-06	0.000166	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—STK11—pancreatic cancer	1.55e-06	0.000164	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	1.52e-06	0.000161	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS2—pancreatic cancer	1.51e-06	0.00016	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.49e-06	0.000158	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.44e-06	0.000153	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	1.43e-06	0.000151	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOE—pancreatic cancer	1.4e-06	0.000149	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	1.4e-06	0.000148	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTEN—pancreatic cancer	1.39e-06	0.000147	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	1.38e-06	0.000146	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.33e-06	0.000141	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.33e-06	0.000141	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTEN—pancreatic cancer	1.32e-06	0.000139	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.31e-06	0.000139	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.27e-06	0.000134	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.25e-06	0.000132	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.23e-06	0.000131	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.22e-06	0.00013	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTEN—pancreatic cancer	1.21e-06	0.000128	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.15e-06	0.000121	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.13e-06	0.00012	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.11e-06	0.000118	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOE—pancreatic cancer	1.08e-06	0.000115	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.08e-06	0.000114	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTEN—pancreatic cancer	9.9e-07	0.000105	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	9.82e-07	0.000104	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	9.77e-07	0.000104	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	9.7e-07	0.000103	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	9.61e-07	0.000102	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPARG—pancreatic cancer	9.43e-07	9.99e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	9.28e-07	9.83e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	8.59e-07	9.1e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	8.51e-07	9.01e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTEN—pancreatic cancer	8.39e-07	8.88e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKT1—pancreatic cancer	8.02e-07	8.5e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	7.59e-07	8.04e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKT1—pancreatic cancer	7.58e-07	8.03e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	7.49e-07	7.93e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	7.42e-07	7.86e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	6.98e-07	7.4e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKT1—pancreatic cancer	6.95e-07	7.36e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTEN—pancreatic cancer	6.47e-07	6.86e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKT1—pancreatic cancer	6.2e-07	6.57e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	5.92e-07	6.27e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKT1—pancreatic cancer	5.7e-07	6.04e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKT1—pancreatic cancer	4.83e-07	5.12e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	4.57e-07	4.84e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKT1—pancreatic cancer	3.73e-07	3.95e-05	CbGpPWpGaD
